Differences in the personality profile of medication-overuse headache sufferers and drug addict patients: A comparative study using MMPI-2

Headache

Volumn 51, Issue 8, 2011, Pages 1212-1227

  Galli, Federica ^a,b   Pozzi, Gino ^c   Frustaci, Alessandra ^d   Allena, Marta ^b   Anastasi, Serena ^e   Chirumbolo, Antonio ^f   Ghiotto, Natascia ^b   Guidetti, Vincenzo ^a   Matarrese, Adriana ^g   Nappi, Giuseppe ^b   Pazzi, Stefania ^b   Quartesan, Roberto ^e   Sances, Grazia ^b   Tassorelli, Cristina ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d IRCCS SAN RAFFAELE PISANA   (Italy)

^e UNIVERSITY OF PERUGIA   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g ASL 10   (Italy)

Author keywords

dependence; drug addiction; medication overuse headache; MMPI 2; personality

Indexed keywords

ADULT; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; DEPRESSION; DRUG DEPENDENCE; DRUG INDUCED HEADACHE; FEMALE; HEADACHE; HUMAN; HYPOCHONDRIASIS; HYSTERIA; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MINNESOTA MULTIPHASIC PERSONALITY INVENTORY; PERSONALITY; POST HOC ANALYSIS; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; FEMALE; HEADACHE DISORDERS, SECONDARY; HUMANS; MALE; MIDDLE AGED; MMPI; PERSONALITY DISORDERS; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC; STRESS, PSYCHOLOGICAL; SUBSTANCE-RELATED DISORDERS;

EID: 80052422548     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2011.01978.x     Document Type: Article

References (59)

1. Katsarava Z, Jensen R,. Medication-overuse headache: Where are we now? Curr Opin Neurol. 2007; 20: 326-330. (Pubitemid 46743116)
2. Pascual J, Colás R, Castillo J,. Epidemiology of chronic daily headache. Curr Pain Headache Rep. 2001; 5: 529-536.
3. Rapoport A, Stang P, Gutterman DL, et al,. Analgesic rebound headache in clinical practice: Data from a physician survey. Headache. 1996; 36: 14-19. (Pubitemid 26045865)
4. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders-2nd edition. Cephalalgia. 2004; 24 (Suppl. 1): 9-160.
5. Headache Classification Committee, Olesen J, Bousser MG, Diener HC, et al,. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006; 26: 742-746.
6. Rossi P, Jensen R, Nappi G, Allena M, COMOESTAS Consortium. A narrative review on the management of medication overuse headache: The steep road from experience to evidence. J Headache Pain. 2009; 10: 407-417.
7. Fritsche G, Eberl A, Katsarava Z, Limmoroth V, Diener HC,. Drug-induced headache: Long-term follow up of withdrawal therapy and persistence of drug misuse. Eur Neurol. 2001; 45: 229-235. (Pubitemid 32521040)
8. Ghiotto N, Sances G, Galli F, et al,. Medication-overuse headache and applicability of the ICHD-II diagnostic criteria: One-year follow-up study (CARE I protocol). Cephalalgia. 2008; 29: 233-243.
9. Grazzi L, Andrasik F, D'Amico D, et al,. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: Outcome at 3 years. Headache. 2002; 59: 1011-1114.
10. Katsarava Z, Muessig M, Dzagnizde A, Fritsche G, Diener HC, Limmroth V,. Medication overuse headache: Rates and predictors for relapse in a 4-year prospective study. Cephalalgia. 2004; 25: 12-15. (Pubitemid 40143787)
11. Diener HC, Dahlöf CGH,. Headache associated with chronic use of substances. In:, Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches, 2nd edn. Philadelphia, PA: Lippincott, Williams & Wilkins; 1999: 671-878.
12. Galli F, Patron L, Russo PM, Bruni O, Ferini-Strambi L, Guidetti V,. Chronic daily headache in childhood and adolescence: Clinical aspects and a 4-year follow-up. Cephalalgia. 2004; 24: 850-858. (Pubitemid 39319182)
13. Guidetti V, Galli F, Fabrizi P, et al,. Headache and psychiatric comorbidity: Clinical aspects and outcome in an 8-year follow-up study. Cephalalgia. 1998; 18: 455-462. (Pubitemid 28459461)
14. Atasoy HT, Atasoy N, Unal AE, Emre U, Sumer M,. Psychiatric comorbidity in medication overuse headache patients with pre-existing headache type of episodic tension-type headache. Eur J Pain. 2005; 9: 285-291. (Pubitemid 40615709)
15. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB,. Transformed migraine and medication overuse in a tertiary headache centre-clinical characteristics and treatment outcomes. Cephalalgia. 2004; 24: 483-490. (Pubitemid 38748030)
16. Fuh JL, Wang SJ, Lu SR, Juang KD,. Does medication overuse headache represent a behavior of dependence? Pain. 2005; 119: 49-55.
17. Fumal A, Laureys S, Di Clemente L, et al,. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain. 2006; 129: 543-550. (Pubitemid 43164376)
18. Ferrari A, Cicero AF, Bertolini A, Leone S, Pasciullo G, Sternieri E,. Need for analgesics/drugs of abuse: A comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ). Cephalalgia. 2006; 26: 187-193.
19. Calabresi P, Cupini LM,. Medication-overuse headache: Similarities with drug addiction. Trends Pharmacol Sci. 2005; 26: 62-68. (Pubitemid 40170167)
20. Radat F, Creac'h C, Guegan-Massardier E, et al,. Behavioral dependence in patients with medication overuse headache: A cross-sectional study in consulting patients using the DSM-IV criteria. Headache. 2008; 48: 1026-1036. (Pubitemid 351952107)
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). International Version with ICD-10 codes. Washington, DC: American Psychiatric Association; 1994.
22. Bigal ME, Sheftell FD, Rapaport AM, Tepper SJ, Weeks R, Baskin SM,. MMPI personality profiles in patients with primary chronic headache: A case-control study. Neurol Sci. 2003; 24: 103-110. (Pubitemid 37304277)
23. Huber D, Henrich G,. Personality traits and stress sensitivity in migraine patients. Behav Med. 2003; 29: 4-13.
24. Ladd JS,. MMPI-2 critical item norms in chemically dependent inpatients. J Clin Psychol. 1996; 52: 367-372. (Pubitemid 26250463)
25. Luconi R, Bartolini M, Taffi R, et al,. Prognostic significance of personality profiles in patients with chronic migraine. Headache. 2007; 47: 1118-1124. (Pubitemid 47457764)
26. Mongini F, Ibertis F, Barbalonga E, Raviola F,. MMPI-2 profiles in chronic daily headache and their relationship to anxiety levels and accompanying symptoms. Headache. 2000; 40: 466-472. (Pubitemid 30421879)
27. Mongini F, Keller R, Deregibus A, Raviola F, Mongini T, Sancarlo M,. Personality traits, depression and migraine in women: A longitudinal study. Cephalalgia. 2003; 23: 186-192. (Pubitemid 36461387)
28. Mongini F, Rota E, Deregibus A, Mura F, Francia Germani A, Mongini T,. A comparative analysis of personality profile and muscle tenderness between chronic migraine and chronic tension-type headache. Neurol Sci. 2005; 26: 203-207. (Pubitemid 41447818)
29. Weybrew BB,. MMPI patterns of physically and psychologically dependent drug abusers. Percept Mot Skills. 1996; 83: 640-642.
30. Clements R, Heintz JM,. Diagnostic accuracy and factor structure of the AAS and APS scales of the MMPI-2. J Pers Assess. 2002; 79: 564-582. (Pubitemid 36015484)
31. Greene RL, Weed NC, Butcher JN, Arredondo R, Davis HG,. A cross-validation of MMPI-2 substance abuse scales. J Pers Assess. 1992; 58: 405-410.
32. Weed NC, Butcher JN, McKenna T, Ben-Porath YS,. New measures for assessing alcohol and drug abuse with the MMPI-2: The APS and AAS. J Pers Assess. 1992; 58: 389-404.
33. Butcher JN, Dahlstrom WG, Graham JR, Tellegen A,. MMPI-2. Minneapolis, MN: Minnesota University Press; 1989.
34. Pancheri P, Sirigatti S,. MMPI-2 (Italian Version). Firenze: Organizzazioni Speciali; 1995.
35. Svanum S, McGrew J, Ehrmann L,. Validity of the substance abuse scales of the MMPI-2 in a college student sample. J Pers Assess. 1994; 62: 427-439.
36. Hervé A,. Holm's sequential Bonferroni procedure. In:, Salkind N, ed. Encyclopedia of Research Design. Thousand Oaks, CA: Sage; 2010: 7-17.
37. Vendrig AA,. The MMPI and chronic pain: A conceptual analysis of a long-standing but complicated relationship. Clin Psychol Rev. 2000; 20: 533-559. (Pubitemid 30326802)
38. Cupini LM, Costa C, Sarchielli P, et al,. Degradation of endocannabinoids in chronic migraine and medication overuse headache. Neurobiol Dis. 2008; 30: 186-189.
39. Elkind AH,. Drug abuse and headache. Med Clin North Am. 1991; 75: 717-732.
40. Ferrari A, Leone S, Tacchi R, et al,. The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients. Cephalalgia. 2009; 29: 31-37.
41. Saper JR, Hamel RL, Lake AE 3rd,. Medication overuse headache (MOH) is a biobehavioural disorder. Cephalalgia. 2005; 25: 545-546. (Pubitemid 40896021)
42. Schnider P, Aull S, Baumgartner C, et al,. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: Five-year follow-up. Cephalalgia. 1996; 16: 481-485. (Pubitemid 26373785)
43. Radat F, Irachabal S, Swendsen J, Henry P,. Analgesic abuse and psychiatric comorbidity in headache patients. Encephale. 2002; 28: 466-471. (Pubitemid 35334154)
44. Fumal A, Laureys S, Di Clemente L, et al,. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain. 2006; 129: 543-550. (Pubitemid 43164376)
45. Radat F, Sakh D, Lutz G, el Amrani M, Ferreri M, Bousser MG,. Psychiatric comorbidity is related to headache induced by chronic substance use in migraineurs. Headache. 1999; 39: 477-480. (Pubitemid 29400298)
46. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC,. Features of medication overuse headache following overuse of different acute headache drugs. Neurology. 2002; 59: 1011-1014.
47. Sbrana A, Bizzarri JV, Rucci P, et al,. The spectrum of substance use in mood and anxiety disorders. Compr Psychiatry. 2005; 46: 6-13. (Pubitemid 39642796)
48. Arena JG, Blanchard EB, Andrasik F, Applebaum K,. Obsessions and compulsions in three kinds of headache sufferers: Analysis of the Maudsley Questionnaire. Behav Res Ther. 1986; 24: 127-132. (Pubitemid 16126617)
49. Papageorgiou C, Rabavilas A, Liappas I, Stefanis C,. Do obsessive-compulsive patients and abstinent heroin addicts share a common psychophysiological mechanism? Neuropsychobiology. 2003; 47: 1-11. (Pubitemid 36469779)
50. Sheftell FD, Atlas SJ,. Migraine and psychiatric comorbidity: From theory and hypotheses to clinical application. Headache. 2002; 42: 934-944. (Pubitemid 35285388)
51. Pancratz L, Hickman DH, Toth S,. The identification and management of drug-seeking behaviour in a medical center. Drug Alcohol Depend. 1989; 24: 115-118. (Pubitemid 19217144)
52. Portenoy RK,. Opioid therapy for chronic non-malignant pain: Current status. In:, Fields HL, Liebeskind JC, eds. Progress in Pain Research and Management. Vol. 1. Seattle, WA: IASP Press; 1994: 247-287.
53. Adams EH, Breiner S, Cicero TJ, Geller A, Inciardi JA, Schnoll SH,. A comparison of the abuse liability of tramadol, NSAIDs and hydrocodone in patients with chronic pain. J Pain Symptom Manage. 2006; 31: 465-476. (Pubitemid 43744403)
54. Aronoff GM,. Opioids in chronic pain management: Is there a significant risk of addiction? Curr Rev Pain. 2000; 4: 112-121.
55. Compton P, Darakjian J, Miotto K,. Screening for addiction in patients with chronic pain and "problematic" substance use: Evaluation of a pilot assessment tool. J Pain Symptom Manage. 1998; 16: 355-363. (Pubitemid 29006198)
56. Weissman DE, Haddox JD,. Opioid pseudoaddiction-an iatrogenic syndrome. Pain. 1989; 36: 363-366. (Pubitemid 19077936)
57. Cloninger CR,. The Temperament and Character Inventory-Revised. St. Louis, MO: Center for Psychobiology of Personality, Washington University; 1999.
58. Janiri L, Martinotti G, Dario T, Schifano F, Bria P,. The gamblers' Temperament and Character Inventory (TCI) personality profile. Subst Use Misuse. 2007; 42: 975-984. (Pubitemid 47037215)
59. Serretti A, Calati R, Giegling I, et al,. 5-HT2A SNPs and the Temperament and Character Inventory. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31: 1275-1281. (Pubitemid 47081316)